Patents by Inventor Sergei Fine

Sergei Fine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8198469
    Abstract: The present invention provides crystalline forms of Tigecycline, and methods of for preparation of crystalline forms and amorphous.
    Type: Grant
    Filed: November 29, 2007
    Date of Patent: June 12, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Tamás Koltai, Sigalit Levi, Leonid Metsger, Michal Rafilovich
  • Patent number: 8198470
    Abstract: The present invention provides processes for the preparation of crystalline forms of Tigecycline.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: June 12, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Sigalit Levi, Michal Rafilovich, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Leonid Metsger, Evgeny Tsiperman
  • Publication number: 20100152142
    Abstract: The present invention provides processes for the preparation of crystalline forms of Tigecycline.
    Type: Application
    Filed: December 1, 2008
    Publication date: June 17, 2010
    Inventors: Sigalit Levi, Michal Rafilovich, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Leonid Metsger, Evgeny Tsiperman
  • Publication number: 20100113527
    Abstract: Provided are crystalline forms of dexLansoprazole, as well as processes for the preparation thereof.
    Type: Application
    Filed: September 30, 2009
    Publication date: May 6, 2010
    Inventors: Jacob RENDELL, Ariel MITTELMAN, Rinat MOSHKOVITS-KAPTSAN, Sergei FINE, Ana KWOKAL, Tamas KOLTAI
  • Patent number: 7605274
    Abstract: This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: April 15, 2008
    Date of Patent: October 20, 2009
    Assignee: Teva Pharmaceutical Industries Ltd
    Inventors: Jean Hildesheim, Sergei Fine, Judith Aronhime, Ben-Zion Dolitzky, Shoshana Ben-Valid, Ilan Kor-Sade
  • Publication number: 20090005453
    Abstract: The present invention provides crystalline forms of Tigecycline, and methods of for preparation of crystalline forms and amorphous.
    Type: Application
    Filed: November 29, 2007
    Publication date: January 1, 2009
    Inventors: Evgeny Tsiperman, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Tamas Koltai, Sigalit Levi, Leonid Metsger, Michal Rafilovich
  • Publication number: 20080234504
    Abstract: The present invention provides substantially pure intermediates, 9-haloacetomidominocyclines, and process of preparing them that are useful for the preparation of glycylcyclines, specifically Tigecycline.
    Type: Application
    Filed: November 30, 2007
    Publication date: September 25, 2008
    Inventors: Evgeny Tsiperman, Sofia Gorohovsky, Slavik Yurkovski, Sergei Fine, Tamas Koltai, Judith Aronhime
  • Publication number: 20080214869
    Abstract: The invention is directed to improved processes of purifying tigecycline.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 4, 2008
    Inventors: Sergei Fine, Slavik Yurkovski, Sofia Gorohovsky-Rosenberg, Evgeny Tsiperman
  • Publication number: 20080146843
    Abstract: The invention is directed to processes for the reduction of tetracycline intermediates having a NO2 group.
    Type: Application
    Filed: May 10, 2007
    Publication date: June 19, 2008
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sergei Fine, Sofia Gorohovsky, Slavik Yurkovski
  • Publication number: 20070244335
    Abstract: Provided is a process for the isolation of tetracycline derivatives.
    Type: Application
    Filed: April 17, 2007
    Publication date: October 18, 2007
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sergei Fine, Sofia Gorohovsky, Slavik Yurkovsky